Literature DB >> 18406257

Molecular Properties of the CRF Receptor.

J Spiess1, F M Dautzenberg, S Sydow, R L Hauger, A Rühmann, T Blank, J Radulovic.   

Abstract

Research into the biology of corticotropin-releasing factor (CRF) has been intensified significantly by the structural characterization of the CRF receptor (CRF-R). Two receptor subtypes, CRF-R1 and CRF-R2, and three functional splice variants of CRF-R2 have been discovered. It appears that ligand binding requires interaction of the N-terminal domain with one or two other extracellular domains of the CRF-R. In contrast to the mammalian CRF-R1, the frog CRF-R1 discriminates between naturally occurring CRF-like peptides.

Entities:  

Year:  1998        PMID: 18406257     DOI: 10.1016/s1043-2760(98)00037-x

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  12 in total

1.  Activation of neuropeptide S-expressing neurons in the locus coeruleus by corticotropin-releasing factor.

Authors:  Kay Jüngling; Xiaobin Liu; Jörg Lesting; Philippe Coulon; L Sosulina; Rainer K Reinscheid; Hans-Christian Pape
Journal:  J Physiol       Date:  2012-05-08       Impact factor: 5.182

2.  Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30.

Authors:  A Rühmann; I Bonk; C R Lin; M G Rosenfeld; J Spiess
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

3.  Corticotropin releasing hormone and related peptides can act as bioregulatory factors in human keratinocytes.

Authors:  A T Slominski; B Roloff; B Zbytek; E T Wei; K Fechner; J Curry; J Wortsman
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-03       Impact factor: 2.416

4.  Functional and protein chemical characterization of the N-terminal domain of the rat corticotropin-releasing factor receptor 1.

Authors:  B A Hofmann; S Sydow; O Jahn; L van Werven; T Liepold; K Eckart; J Spiess
Journal:  Protein Sci       Date:  2001-10       Impact factor: 6.725

5.  A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonists.

Authors:  K Eckart; O Jahn; J Radulovic; H Tezval; L van Werven; J Spiess
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

6.  cAMP- and Ca²(+) /calmodulin-dependent protein kinases mediate inotropic, lusitropic and arrhythmogenic effects of urocortin 2 in mouse ventricular myocytes.

Authors:  Li-Zhen Yang; Jens Kockskämper; Shelina Khan; Jorge Suarez; Stefanie Walther; Bernhard Doleschal; Gregor Unterer; Mounir Khafaga; Heinrich Mächler; Frank R Heinzel; Wolfgang H Dillmann; Burkert Pieske; Joachim Spiess
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

7.  Hypoactivation of CRF receptors, predominantly type 2, in the medial-posterior BNST is vital for adequate maternal behavior in lactating rats.

Authors:  Stefanie M Klampfl; Paula J Brunton; Doris S Bayerl; Oliver J Bosch
Journal:  J Neurosci       Date:  2014-07-16       Impact factor: 6.167

Review 8.  Corticotropin-releasing factor peptide antagonists: design, characterization and potential clinical relevance.

Authors:  Jean E Rivier; Catherine L Rivier
Journal:  Front Neuroendocrinol       Date:  2013-11-20       Impact factor: 8.606

Review 9.  Anorexia nervosa: a unified neurological perspective.

Authors:  Tasneem Fatema Hasan; Hunaid Hasan
Journal:  Int J Med Sci       Date:  2011-10-22       Impact factor: 3.738

10.  Corticotropin-releasing factor facilitates epileptiform activity in the entorhinal cortex: roles of CRF2 receptors and PKA pathway.

Authors:  Lalitha Kurada; Chuanxiu Yang; Saobo Lei
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.